The Immunobuddies Podcast shared a post on LinkedIn:
“The UK is pushing 40°C… so if you’re looking for an excuse to stay out of the heat, we’ve got you covered!
Grab a cold drink, find some shade, and tune in to the latest episode of the Immunobuddies Bladder Cancer Reimagined mini-series.
Episode 202: Bladder Cancer Reimagined – Part 4: Metastatic Disease and the Evolution of ADC and Checkpoint Inhibitor Synergy.
Join Associate Professor Will Ince as he explores the rapidly evolving treatment landscape for metastatic bladder cancer, including:
- The evolution of antibody-drug conjugates (ADCs).
- Checkpoint inhibitor synergy and combination strategies.
- How emerging evidence is changing clinical practice.
- What the future holds for patients with advanced bladder cancer.
Whether you’re escaping the heat or simply catching up on the latest developments in uro-oncology, this episode is well worth a listen.
Listen now.
Stay cool, stay hydrated, and enjoy the episode!”
Other articles about The Immunobuddies Podcast on OncoDaily.